chronic kidney disease Archives - Express Pharma

Recent study shows BioCity’s potential to differentiate in kidney disease space

Diagnosed prevalent cases of chronic kidney disease to reach 22.97 million across 7MM in 2033, predicts GlobalData

New Drug Application of Zydus’ Desidustat tablets by China Medical System Holdings accepted in China

Bayer, Sun Pharma sign marketing and distribution pact for second brand of Finerenone

Sun Pharma, Zydus sign licensing pact to co-market Desidustat for CKD treatment in India

Pari CKDu Foundation, Tanker Foundation and Centaur Pharma join hands to fight CKDu

Japan approves Forxiga to treat chronic kidney disease in patients with and without type-II diabetes

Bayer gets US FDA nod for KERENDIA (finerenone) to treat CKD associated with type 2 diabetes

Lupin gets US FDA approval for Sevelamer Hydrochloride Tablets

JBCPL forays into nephrology segment in India with new division called RENOVA